LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence company, announced today that it has reached commercial terms with two leading pharmacy retail operators in Caracas, Venezuela, to support the planned deployment of its AI-powered prescription processing and pharmaceutical fulfillment platform. The initiative is expected to modernize traditional prescription workflows through mobile-enabled intake, AI-based text recognition, automated inventory verification, fulfillment coordination, and delivery routing technologies.
Venezuela is the initial target market due to increasing interest in technology-enabled healthcare infrastructure and opportunities for operational modernization in the country's pharmaceutical distribution sector. Management believes the deployment will provide a framework for evaluating future expansion into additional South American markets as part of the company's broader regional commercialization strategy.
The platform is designed to address operational inefficiencies in underserved healthcare distribution markets across Latin America. Under the planned initiative, participating pharmacy operators are expected to benefit from improved prescription processing efficiency, reduced administrative overhead, optimized inventory coordination, and enhanced customer accessibility through technology-enabled fulfillment and delivery systems.
Management highlighted several commercial advantages of the initiative, including initial entry into an active pharmaceutical retail environment in a major Latin American metropolitan market, real-world evaluation of the healthcare logistics platform, potential recurring transaction-based revenue from prescription fulfillment volumes, and a scalable framework for regional expansion.
The pharmacy fulfillment initiative is intended to integrate with LataMed's broader digital healthcare ecosystem, which includes telehealth applications, healthcare analytics infrastructure, patient engagement technologies, and AI-assisted healthcare coordination platforms. Management believes this integration will enhance operational scalability, improve user accessibility, support future platform interoperability, and strengthen the company's long-term digital healthcare commercialization strategy throughout Latin America.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We believe pharmacy fulfillment represents a natural extension of our digital healthcare infrastructure strategy. By combining AI-enabled prescription processing, logistics coordination, and pharmacy retail participation, we are continuing development of healthcare technology solutions designed to support accessibility, operational efficiency, and scalability across Latin America.”
The company cautioned that the pharmacy fulfillment platform and related deployment activities remain subject to continued operational planning, technology integration, commercial readiness, regulatory considerations, partner implementation timelines, financing availability, and market adoption. No assurance can be provided regarding the timing of broader commercial deployment, transaction volumes, revenue generation, geographic expansion, or operational success.
LataMed AI Corp. is a development-stage company focused on building scalable telehealth infrastructure and healthcare analytics platforms for emerging markets, with an initial emphasis on Latin America. The company is advancing a technology-enabled healthcare ecosystem designed to support remote patient engagement, provider coordination, healthcare analytics, emergency response integration, pharmaceutical logistics, and broader digital healthcare delivery initiatives.
For more information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
